About Cheilbio
Cheilbio is a company based in Yongin (South Korea) founded in 1977. Cheilbio offers products and services including Resume Writing Service, Cover Letter Samples, and Online Consultation. Cheilbio operates in a competitive market with competitors including Zoetis, Ceva, Bio-Sourcing, Phage Lab and Proteon Pharmaceuticals, among others.
- Headquarter Yongin, South Korea
- Stage Public
- SectorsHealthcareAgriculture
- Phone•••• ••••
- Website cheilbio.com
- Legal Name Cheil Bio Co., Ltd.
- Annual Revenue$9.43 M (USD)41.59as on Dec 31, 2024
- Net Profit-$282.43 K (USD)71.19as on Dec 31, 2024
- EBITDA-$493.84 K (USD)64.53as on Dec 31, 2024
Associated legal entities of Cheilbio
Cheilbio operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of Cheilbio
Cheilbio offers a comprehensive portfolio of products and services, including Resume Writing Service, Cover Letter Samples, and Online Consultation.
Professional assistance for creating tailored resumes for job applications.
Provides sample templates for effective job application letters.
Offers guidance on career documents via online platforms.
People of Cheilbio
1 people are tracked at Cheilbio (1 in leadership).
| Name | Role | Group |
|---|---|---|
Gwang Gyeong Shim | CEO | Leadership |
Complete people profiles for Cheilbio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Cheilbio
Cheilbio is a publicly listed company on the KRX with ticker symbol 052670 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date24 Jan 2002
- Listed onKRX: 52670
- Listed entityCheil Bio Co., Ltd.
- Exchange sectorHealth technology
- Share price625,000.00 KRW (+29948.08% on the day) · 2026-02-09
- Market capitalisation56,965,358,887.00 KRW
- Volume (last session)6,333
- Analyst consensusNo rating
Financials of Cheilbio
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | 13.91B KRW | -416.6M KRW | -728.4M KRW |
| 2023 | 9.82B KRW | -1.45B KRW | -2.05B KRW |
| 2022 | 15.35B KRW | -1.71B KRW | -1.18B KRW |
| 2021 | 16.91B KRW | -712.4M KRW | -1.40B KRW |
| 2020 | 19.00B KRW | 993.8M KRW | -124.6M KRW |
Balance sheet, profit and loss, cash flow and ratios of , are on its company page.
Detailed financial statements for Cheilbio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Cheilbio
Cheilbio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, Bio-Sourcing, Phage Lab and Proteon Pharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zoetis.com | 2012 | Brussels, Belgium | – | 9,200 | Animal medicines, vaccines, and diagnostics are manufactured and supplied. | |
| ceva.com | 1999 | Libourne, France | $214.35M | – | Animal health therapeutics are developed and supplied globally by Ceva. | |
| bio-sourcing.com | 2014 | Liege, Belgium | $17.36M | – | Biopharmaceuticals for animals are manufactured and supplied through partnerships. | |
| phage-lab.com | 2010 | Macul, Chile | $41M | – | Bacteriophage treatments for animal infections are developed by the company. | |
| proteonpharma.com | 2005 | Lodz, Poland | $28.79M | – | Therapeutics for animal infectious diseases are developed via phage platforms. | |
| animab.com | 2020 | Ghent, Belgium | $13.97M | 3 | Proprietary monoclonal antibody platform is provided for pig intestinal infections. | |
| aquiloncyl.com | 2012 | Leon, Spain | $3.79M | – | Products enhancing animal productivity are developed and marketed. | |
| obione.fr | 2008 | Macon, France | $1.12M | – | Herd management software and inorganic feed additives for livestock animals | |
| oncovet-clinical-research.com | 2011 | Loos, France | $2.75M | – | Manufacturer of medicines & nutraceutical products for pet health |
Detailed competitors of Cheilbio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Cheilbio
10 companies that operate in the same segment as Cheilbio (Veterinary Digital Health), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Practice and prescription management software is provided for veterinary professionals. | 2010 | Portland, Oregon, United States | USD 291.64 M | – | – | |
Animal medicines, vaccines, and diagnostics are manufactured and supplied. | 2012 | Brussels, Brussels-capital Region, Belgium | – | – | – | |
Veterinary pharmacy services are delivered by VetSource to practices. | 2005 | Portland, Oregon, United States | USD 81.25 M | – | – | |
Animal health therapeutics are developed and supplied globally by Ceva. | 1999 | Libourne, Nouvelle-aquitaine, France | USD 214.35 M | – | – | |
Digital platform for pet insurance | 2020 | Stockholm, Sweden | USD 114.08 M | – | – | |
App based platform providing veterinary services and clinical management solutions for veterinarians | 2018 | Beverly Hills, California, United States | USD 58.81 M | – | – | |
Online client communication platform for veterinary doctors | 2013 | San Diego, California, United States | USD 14.11 M | USD 14.38 M | 1 | |
Virtual veterinary care is provided via an app platform. | 2018 | Los Angeles, California, United States | USD 210 M | – | 163 | |
Comprehensive customer engagement platform for veterinary clinics is provided. | 2015 | Austin, Texas, United States | USD 50.3 M | – | – | |
Veterinary appointments are booked via an online platform. | 2017 | Brooklyn, New York, United States | USD 243 M | – | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cheilbio
Cheilbio was founded in 1977.
Cheilbio is headquartered in Yongin, South Korea. It is registered at Yongin, Gyeonggi, South Korea.
Gwang Gyeong Shim is the current CEO of Cheilbio.
Annual revenue of Cheilbio is $9.43M as on Dec 31, 2024.
The company was founded in 1977 and focuses on the livestock health sector. Disease prevention solutions and treatment aids are developed through research and development efforts. Therapeutic products, including antifungal antibiotics and colistin strains used as feed additives, have been created. Diagnostic kits for chicken salmonella antibodies via ELISA and parvovirus detection through immunochromatography are provided. Complex probiotic enzymes are produced from designated waste clay.
Cheilbio's top competitors include Zoetis, Ceva and Bio-Sourcing.
Cheilbio offers Resume Writing Service, Cover Letter Samples, and Online Consultation.
Yes, Cheilbio is publicly traded on KRX under the ticker symbol 052670.
Cheilbio operates through ,.